Transaction Details

Footnotes

Represents 34,743 and 7,047 shares of Company common stock issued under performance share awards granted to the reporting person on March 28, 2025 (the "March 2025 Grant") and March 31, 2023 (the "March 2023 Grant"), respectively. The awards are subject to performance-vesting restrictions based on EBITDA, free cash flow and other performance criteria for the performance period from January 1, 2025 to December 31, 2025. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Company's Board of Directors. The shares of the March 2025 Grant will vest equally on March 28, 2026, March 28, 2027 and March 28, 2028, subject to the reporting person's continued service and good standing through each applicable vesting date. The shares of the March 2023 Grant will vest on March 31, 2026.